Summary
Highlights
Dr. Sandra Black, co-principal investigator, expresses excitement about the possibilities this technology presents for Alzheimer's treatment. However, she emphasizes the importance of taking it 'one step at a time' and ensuring the procedure's safety, as Rick undergoes close observation with follow-up scans and tests.
Sunnybrook researchers made history in 2015 by non-invasively opening the blood-brain barrier in a person. Rick is the first Alzheimer's patient to receive this procedure. Dr. Kullervo Hynynen, who helped develop the technology, notes the satisfaction of reaching this point but acknowledges 'a long way to go' with years of experience needed before widespread use. The study will include five additional Alzheimer's patients.
Rick Karr, inspired by his Alzheimer's diagnosis, expresses himself through music. He becomes the first Alzheimer's patient globally to participate in a study using focused ultrasound, aiming to change disease treatment by opening the blood-brain barrier.
Focused ultrasound technology uses a specialized helmet device and microbubbles to temporarily open the blood-brain barrier, which acts like a protective plastic wrap around the brain. This opening creates a doorway to deliver medications directly and non-invasively to previously inaccessible brain regions.
Dr. Nir Lipsman, the lead investigator, highlights that this is a phase one study focused on safety. Initial results show that the attempt to open the blood-brain barrier with focused ultrasound was successful, as evidenced by contrast enhancement in the targeted regions of Rick's brain after two treatments.
With one person diagnosed with Alzheimer's every three seconds worldwide, there's a critical need for new approaches. Focused ultrasound is seen as a revolutionary way to get important drugs into the brain. Rick, driven by a desire to help others, embodies the spirit of these pioneering efforts.